# All Registered Polls

The table below lists all polls registered and analyzed so far.

| Period     | Polling firm/Commissioner(s) | ÖVP | SPÖ | FPÖ | Grüne | NEOS | JETZT | GILT | HC |
|:----------:|:----------------------------:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|:--:|
| 26 May 2019 | General Election | 34.6% <br> 7 | 23.9% <br> 5 | 17.2% <br> 3 | 14.1% <br> 2 | 8.4% <br> 1 | 1.0% <br> 0 | 0.0% <br> 0 | 0.0% <br> 0 |
| [8–11 May 2023](2023-05-11-UniqueResearch.html) | Unique Research <br> profil | 20–26% <br> 4–5 | 20–26% <br> 4–5 | 26–32% <br> 5–7 | 8–12% <br> 1–2 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [28 April–10 May 2023](2023-05-10-Market.html) | Market <br> ÖSTERREICH | 19–23% <br> 4 | 23–27% <br> 5 | 24–28% <br> 5–6 | 11–14% <br> 2 | 9–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [24 April–4 May 2023](2023-05-04-OGM.html) | OGM <br> KURIER | 21–25% <br> 4–5 | 18–22% <br> 4 | 26–30% <br> 5–6 | 8–10% <br> 1–2 | 8–10% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [2–4 May 2023](2023-05-04-INSA.html) | INSA <br> eXXpress | 20–26% <br> 4–5 | 20–26% <br> 4–5 | 27–33% <br> 5–7 | 7–11% <br> 1–2 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [28 April–3 May 2023](2023-05-03-Market.html) | Market <br> ÖSTERREICH | 19–23% <br> 4 | 23–27% <br> 4–5 | 26–30% <br> 5–6 | 9–11% <br> 1–2 | 10–12% <br> 2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [29 April–1 May 2023](2023-05-01-IFDD.html) | IFDD <br> BVZ | 22–26% <br> 4–6 | 20–24% <br> 4–5 | 25–30% <br> 5–6 | 8–11% <br> 1–2 | 7–10% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [24–27 April 2023](2023-04-27-PeterHajek.html) | Peter Hajek <br> APA, ATV and PULS 24 | 21–27% <br> 4–6 | 19–25% <br> 4–5 | 26–32% <br> 5–7 | 8–12% <br> 1–2 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [24–26 April 2023](2023-04-26-OGM.html) | OGM <br> Servus TV | 21–26% <br> 4–5 | 18–23% <br> 3–5 | 26–32% <br> 5–7 | 7–11% <br> 1–2 | 7–10% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [24–26 April 2023](2023-04-26-Market.html) | Market <br> ÖSTERREICH | 20–25% <br> 4–5 | 20–25% <br> 4–5 | 25–31% <br> 5–7 | 7–11% <br> 1–2 | 9–13% <br> 2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [3–12 April 2023](2023-04-12-Market.html) | Market | 18–22% <br> 3–4 | 23–27% <br> 4–5 | 26–30% <br> 5–6 | 10–12% <br> 2 | 13–16% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [3–6 April 2023](2023-04-06-INSA.html) | INSA <br> eXXpress | 20–25% <br> 4–5 | 22–28% <br> 4–6 | 25–31% <br> 5–6 | 7–11% <br> 1–2 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [27 March–5 April 2023](2023-04-05-Market.html) | Market | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [27–29 March 2023](2023-03-29-Market.html) | Market <br> ÖSTERREICH | 19–24% <br> 4–5 | 19–24% <br> 4–5 | 26–32% <br> 5–6 | 8–12% <br> 1–2 | 11–15% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [20–23 March 2023](2023-03-23-UniqueResearch.html) | Unique Research <br> Heute | 22–28% <br> 4–6 | 21–27% <br> 4–6 | 25–31% <br> 5–6 | 9–13% <br> 1–2 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [20–23 March 2023](2023-03-23-OGM.html) | OGM <br> KURIER | 21–26% <br> 4–5 | 21–26% <br> 4–5 | 25–31% <br> 5–6 | 8–12% <br> 1–2 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [20–23 March 2023](2023-03-23-Market.html) | Market <br> Der Standard | 20–26% <br> 4–5 | 18–24% <br> 3–5 | 26–32% <br> 5–7 | 8–12% <br> 1–2 | 9–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [20–22 March 2023](2023-03-22-Market.html) | Market <br> ÖSTERREICH | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [6–9 March 2023](2023-03-09-UniqueResearch.html) | Unique Research <br> profil | 19–25% <br> 4–5 | 22–28% <br> 4–6 | 28–34% <br> 6–7 | 8–12% <br> 1–2 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [6–9 March 2023](2023-03-09-INSA.html) | INSA <br> eXXpress | 20–25% <br> 4–5 | 23–29% <br> 5–6 | 24–30% <br> 5–6 | 7–11% <br> 1–2 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [17–21 February 2023](2023-02-21-Market.html) | Market <br> Der Standard | 19–25% <br> 4–5 | 21–27% <br> 4–5 | 25–31% <br> 5–6 | 8–12% <br> 1–2 | 9–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [13–16 February 2023](2023-02-16-UniqueResearch.html) | Unique Research <br> profil | 21–27% <br> 4–6 | 21–27% <br> 4–6 | 26–32% <br> 5–7 | 8–12% <br> 1–2 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [12–16 February 2023](2023-02-16-OGM.html) | OGM <br> KURIER | 20–25% <br> 4–5 | 21–27% <br> 4–5 | 24–30% <br> 5–6 | 8–12% <br> 1–2 | 9–13% <br> 2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [6–9 February 2023](2023-02-09-INSA.html) | INSA <br> eXXpress | 19–24% <br> 3–5 | 21–27% <br> 4–5 | 25–31% <br> 5–6 | 8–12% <br> 1–2 | 9–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [16–19 January 2023](2023-01-19-UniqueResearch.html) | Unique Research <br> profil | 19–25% <br> 4–5 | 21–27% <br> 4–6 | 25–31% <br> 5–7 | 10–14% <br> 2–3 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [16–18 January 2023](2023-01-18-OGM.html) | OGM | 19–25% <br> 4–5 | 22–28% <br> 4–6 | 24–30% <br> 5–6 | 8–12% <br> 1–2 | 9–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [2–5 January 2023](2023-01-05-INSA.html) | INSA <br> eXXpress | 20–25% <br> 4–5 | 22–28% <br> 4–6 | 25–31% <br> 5–7 | 7–11% <br> 1–2 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [12–15 December 2022](2022-12-15-PeterHajek.html) | Peter Hajek <br> APA and ATV | 20–26% <br> 4–5 | 22–28% <br> 4–6 | 24–30% <br> 5–6 | 9–14% <br> 2–3 | 9–14% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [5–9 December 2022](2022-12-09-INSA.html) | INSA <br> eXXpress | 19–24% <br> 4–5 | 24–30% <br> 5–6 | 23–29% <br> 5–6 | 8–12% <br> 1–2 | 6–10% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [2–7 December 2022](2022-12-07-UniqueResearch.html) | Unique Research <br> profil | 17–23% <br> 3–5 | 23–29% <br> 5–6 | 23–29% <br> 5–6 | 9–13% <br> 1–3 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [3–5 December 2022](2022-12-05-Market.html) | Market <br> Der Standard | 18–24% <br> 3–5 | 24–30% <br> 5–6 | 26–32% <br> 5–7 | 8–12% <br> 1–2 | 9–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [21–23 November 2022](2022-11-23-Market.html) | Market <br> ÖSTERREICH | 18–22% <br> 3–4 | 23–27% <br> 5 | 24–28% <br> 5–6 | 9–11% <br> 1–2 | 12–15% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [14–16 November 2022](2022-11-16-Market.html) | Market <br> ÖSTERREICH | 20–24% <br> 4–5 | 25–29% <br> 5–6 | 23–27% <br> 5–6 | 9–11% <br> 1–2 | 11–14% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [7–10 November 2022](2022-11-10-UniqueResearch.html) | Unique Research <br> profil | 19–25% <br> 4–5 | 24–30% <br> 5–6 | 22–28% <br> 4–6 | 8–12% <br> 1–2 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [7–9 November 2022](2022-11-09-Market.html) | Market <br> ÖSTERREICH | 20–24% <br> 4–5 | 25–29% <br> 5–6 | 22–26% <br> 4–5 | 10–12% <br> 2 | 11–14% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [2–4 November 2022](2022-11-04-INSA.html) | INSA <br> eXXpress | 19–24% <br> 4–5 | 26–32% <br> 5–7 | 20–26% <br> 4–5 | 8–12% <br> 1–2 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [31 October–2 November 2022](2022-11-02-Market.html) | Market <br> ÖSTERREICH | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [26–28 October 2022](2022-10-28-IFDD.html) | IFDD <br> PULS 24 | 18–22% <br> 3–4 | 25–30% <br> 5–6 | 23–28% <br> 4–5 | 9–13% <br> 2 | 9–13% <br> 2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [17–25 October 2022](2022-10-25-Market.html) | Market <br> ÖSTERREICH | 19–23% <br> 4–5 | 24–28% <br> 5–6 | 24–28% <br> 5–6 | 10–12% <br> 2 | 10–12% <br> 2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [17–19 October 2022](2022-10-19-Market.html) | Market <br> ÖSTERREICH | 20–24% <br> 4–5 | 25–29% <br> 5–6 | 23–27% <br> 5–6 | 9–11% <br> 1–2 | 9–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [10–14 October 2022](2022-10-14-IFDD.html) | IFDD <br> PULS 24 | 21–26% <br> 4–5 | 25–31% <br> 5–6 | 21–27% <br> 4–5 | 8–12% <br> 1–2 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [10–13 October 2022](2022-10-13-UniqueResearch.html) | Unique Research <br> profil | 20–26% <br> 4–5 | 25–31% <br> 5–6 | 21–27% <br> 4–6 | 9–13% <br> 1–2 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [10–12 October 2022](2022-10-12-Market.html) | Market <br> ÖSTERREICH | 20–24% <br> 4–5 | 26–30% <br> 5–6 | 23–27% <br> 5–6 | 9–11% <br> 1–2 | 9–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [4–6 October 2022](2022-10-06-INSA.html) | INSA <br> eXXpress | 20–25% <br> 4–5 | 25–31% <br> 5–6 | 20–26% <br> 4–5 | 8–12% <br> 1–2 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [3–5 October 2022](2022-10-05-Market.html) | Market <br> ÖSTERREICH | 20–24% <br> 4–5 | 26–30% <br> 5–6 | 22–26% <br> 4–5 | 8–10% <br> 1–2 | 11–14% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [23–28 September 2022](2022-09-28-OGM.html) | OGM <br> KURIER | 20–25% <br> 4–5 | 25–31% <br> 5–6 | 20–25% <br> 4–5 | 8–12% <br> 1–2 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [19–27 September 2022](2022-09-27-Market.html) | Market <br> ÖSTERREICH | 19–23% <br> 4–5 | 25–29% <br> 5–6 | 22–26% <br> 4–5 | 9–11% <br> 1–2 | 11–14% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [19–20 September 2022](2022-09-20-Market.html) | Market <br> ÖSTERREICH | 18–22% <br> 4 | 26–30% <br> 5–6 | 21–25% <br> 4–5 | 10–12% <br> 2 | 11–14% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [7–15 September 2022](2022-09-15-UniqueResearch.html) | Unique Research <br> profil | 19–23% <br> 4–5 | 27–31% <br> 5–7 | 21–25% <br> 4–5 | 10–13% <br> 2 | 8–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [12–13 September 2022](2022-09-13-Market.html) | Market <br> ÖSTERREICH | 18–22% <br> 4–5 | 26–30% <br> 5–6 | 20–24% <br> 4–5 | 11–14% <br> 2–3 | 12–15% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [5–8 September 2022](2022-09-08-INSA.html) | INSA <br> eXXpress | 18–23% <br> 3–5 | 26–32% <br> 5–7 | 19–24% <br> 3–5 | 8–12% <br> 1–2 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [5–6 September 2022](2022-09-06-Market.html) | Market <br> ÖSTERREICH | 18–22% <br> 4–5 | 27–31% <br> 6–7 | 20–24% <br> 4–5 | 9–11% <br> 1–2 | 12–15% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [29–30 August 2022](2022-08-30-Market.html) | Market <br> ÖSTERREICH | 19–23% <br> 4–5 | 28–32% <br> 6–7 | 20–24% <br> 4–5 | 8–10% <br> 1–2 | 10–12% <br> 2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [22–23 August 2022](2022-08-23-Market.html) | Market <br> ÖSTERREICH | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [10–18 August 2022](2022-08-18-UniqueResearch.html) | Unique Research <br> profil | 19–23% <br> 4–5 | 26–30% <br> 5–7 | 20–24% <br> 4–5 | 10–13% <br> 2 | 10–13% <br> 2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [9–17 August 2022](2022-08-17-Market.html) | Market <br> ÖSTERREICH | 19–23% <br> 4–5 | 28–32% <br> 6–7 | 19–23% <br> 4–5 | 8–10% <br> 1–2 | 12–15% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [8–11 August 2022](2022-08-11-Market.html) | Market <br> Der Standard | 19–25% <br> 4–5 | 27–33% <br> 6–7 | 18–24% <br> 4–5 | 9–13% <br> 2–3 | 9–13% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [8–9 August 2022](2022-08-09-Market.html) | Market <br> ÖSTERREICH | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [1–4 August 2022](2022-08-04-INSA.html) | INSA <br> eXXpress | 18–23% <br> 3–5 | 26–32% <br> 5–7 | 19–24% <br> 3–5 | 8–12% <br> 1–2 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [1–2 August 2022](2022-08-02-Market.html) | Market <br> ÖSTERREICH | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [25–27 July 2022](2022-07-27-Market.html) | Market <br> ÖSTERREICH | 19–23% <br> 4–5 | 27–31% <br> 5–7 | 21–25% <br> 4–5 | 9–11% <br> 1–2 | 10–12% <br> 2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [18–20 July 2022](2022-07-20-Market.html) | Market <br> ÖSTERREICH | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [16 July 2022](2022-07-16-INSA.html) | INSA <br> eXXpress | 19–24% <br> 4–5 | 27–33% <br> 5–7 | 18–23% <br> 3–5 | 8–12% <br> 1–2 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [10–14 July 2022](2022-07-14-UniqueResearch.html) | Unique Research <br> profil | 19–25% <br> 4–5 | 26–32% <br> 5–7 | 18–24% <br> 4–5 | 8–12% <br> 1–2 | 9–13% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [11–13 July 2022](2022-07-13-Market.html) | Market <br> ÖSTERREICH | 19–23% <br> 4–5 | 27–31% <br> 6–7 | 20–24% <br> 4–5 | 9–11% <br> 2 | 11–14% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [4–6 July 2022](2022-07-06-Market.html) | Market <br> ÖSTERREICH | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [30 June–3 July 2022](2022-07-03-IFDD.html) | IFDD <br> PULS 24 | 18–23% <br> 3–5 | 28–34% <br> 6–7 | 19–24% <br> 4–5 | 8–12% <br> 1–2 | 9–13% <br> 2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [27–30 June 2022](2022-06-30-PeterHajek.html) | Peter Hajek <br> APA and ATV | 19–25% <br> 4–5 | 26–32% <br> 5–7 | 19–25% <br> 4–5 | 8–12% <br> 1–2 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [27–28 June 2022](2022-06-28-Market.html) | Market <br> ÖSTERREICH and POLITIK LIVE | 19–23% <br> 4–5 | 29–33% <br> 6–7 | 20–24% <br> 4–5 | 9–11% <br> 1–2 | 8–10% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [20–23 June 2022](2022-06-23-UniqueResearch.html) | Unique Research <br> Heute | 18–24% <br> 4–5 | 28–34% <br> 6–7 | 16–22% <br> 3–4 | 9–13% <br> 1–2 | 9–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [20–23 June 2022](2022-06-23-OGM.html) | OGM <br> KURIER | 20–26% <br> 4–5 | 26–32% <br> 5–7 | 17–22% <br> 3–4 | 8–12% <br> 1–2 | 9–13% <br> 2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [13–21 June 2022](2022-06-21-Market.html) | Market <br> ÖSTERREICH | 19–23% <br> 4–5 | 29–33% <br> 6–7 | 19–23% <br> 4–5 | 8–10% <br> 1–2 | 10–12% <br> 2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [7–14 June 2022](2022-06-14-Market.html) | Market <br> ÖSTERREICH | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [10–14 June 2022](2022-06-14-INSA.html) | INSA <br> eXXpress | 20–25% <br> 4–5 | 26–32% <br> 5–7 | 18–23% <br> 3–5 | 8–12% <br> 1–2 | 9–13% <br> 2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [7–11 June 2022](2022-06-11-IFDD.html) | IFDD <br> Kronen Zeitung | 19–23% <br> 4–5 | 29–34% <br> 6–7 | 18–22% <br> 3–5 | 8–11% <br> 1–2 | 9–13% <br> 2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [7–9 June 2022](2022-06-09-UniqueResearch.html) | Unique Research <br> profil | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [7–8 June 2022](2022-06-08-Market.html) | Market <br> ÖSTERREICH | 19–23% <br> 4–5 | 30–34% <br> 6–7 | 17–21% <br> 3–4 | 8–10% <br> 1–2 | 11–14% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [30 May–1 June 2022](2022-06-01-Market.html) | Market <br> ÖSTERREICH | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [23–25 May 2022](2022-05-25-Market.html) | Market <br> Der Standard | 20–26% <br> 4–5 | 26–32% <br> 5–7 | 18–23% <br> 3–5 | 8–12% <br> 1–2 | 9–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [21–24 May 2022](2022-05-24-Market.html) | Market <br> ÖSTERREICH | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [16–19 May 2022](2022-05-19-Market.html) | Market <br> ÖSTERREICH and POLITIK LIVE | 21–25% <br> 4–5 | 27–31% <br> 5–6 | 19–23% <br> 4–5 | 8–10% <br> 1–2 | 10–12% <br> 2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [9–12 May 2022](2022-05-12-UniqueResearch.html) | Unique Research <br> profil | 19–25% <br> 4–5 | 24–30% <br> 5–6 | 17–23% <br> 3–5 | 10–14% <br> 2–3 | 9–13% <br> 2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [9–11 May 2022](2022-05-11-Market.html) | Market <br> ÖSTERREICH and POLITIK LIVE | 22–25% <br> 4–5 | 26–30% <br> 5–6 | 19–22% <br> 4 | 8–11% <br> 1–2 | 11–14% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [29 April–5 May 2022](2022-05-05-OGM.html) | OGM <br> KURIER | 23–29% <br> 5–6 | 23–29% <br> 5–6 | 15–21% <br> 3–4 | 10–14% <br> 2–3 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [25 April–5 May 2022](2022-05-05-Market.html) | Market <br> ÖSTERREICH | 22–26% <br> 4–5 | 26–30% <br> 5–6 | 16–20% <br> 3–4 | 10–12% <br> 2 | 10–12% <br> 2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [25–28 April 2022](2022-04-28-PeterHajek.html) | Peter Hajek <br> APA and ATV | 23–29% <br> 5–6 | 23–29% <br> 5–6 | 15–21% <br> 3–4 | 10–14% <br> 2–3 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [22–26 April 2022](2022-04-26-UniqueResearch.html) | Unique Research <br> Heute | 21–27% <br> 4–6 | 25–31% <br> 5–6 | 16–22% <br> 3–4 | 9–13% <br> 1–2 | 10–14% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [4–7 April 2022](2022-04-07-UniqueResearch.html) | Unique Research <br> profil | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [21–24 March 2022](2022-03-24-UniqueResearch.html) | Unique Research <br> Heute | 19–25% <br> 4–5 | 26–32% <br> 5–7 | 16–22% <br> 3–4 | 9–13% <br> 2–3 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [22–24 March 2022](2022-03-24-OGM.html) | OGM <br> KURIER | 23–29% <br> 5–6 | 23–29% <br> 5–6 | 16–21% <br> 3–4 | 9–13% <br> 2 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [21–24 March 2022](2022-03-24-IFDD.html) | IFDD <br> PULS 24 | 20–26% <br> 4–5 | 25–31% <br> 5–6 | 17–22% <br> 3–4 | 7–11% <br> 1–2 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [3–10 March 2022](2022-03-10-UniqueResearch.html) | Unique Research <br> profil | 20–26% <br> 4–5 | 24–30% <br> 5–6 | 16–22% <br> 3–4 | 9–13% <br> 1–2 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [21 February–3 March 2022](2022-03-03-IFDD.html) | IFDD <br> Kronen Zeitung | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [21–24 February 2022](2022-02-24-PeterHajek.html) | Peter Hajek <br> APA and ATV | 20–26% <br> 4–5 | 22–28% <br> 4–6 | 17–23% <br> 3–5 | 9–13% <br> 2–3 | 9–13% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [18–22 February 2022](2022-02-22-Market.html) | Market <br> Der Standard | 21–27% <br> 4–6 | 24–30% <br> 5–6 | 17–23% <br> 3–5 | 9–13% <br> 1–2 | 10–14% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [7–10 February 2022](2022-02-10-UniqueResearch.html) | Unique Research <br> profil | 21–27% <br> 4–6 | 22–28% <br> 4–6 | 15–21% <br> 3–4 | 11–16% <br> 2–3 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [10–13 January 2022](2022-01-13-UniqueResearch.html) | Unique Research <br> profil | 21–29% <br> 4–6 | 21–29% <br> 4–6 | 17–24% <br> 3–5 | 9–14% <br> 1–3 | 9–14% <br> 1–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [23–28 December 2021](2021-12-28-Market.html) | Market <br> Der Standard | 21–27% <br> 4–6 | 23–29% <br> 5–6 | 18–24% <br> 4–5 | 10–14% <br> 2–3 | 9–13% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [13–16 December 2021](2021-12-16-PeterHajek.html) | Peter Hajek <br> APA and ATV | 24–30% <br> 5–6 | 22–28% <br> 4–6 | 15–20% <br> 3–4 | 12–17% <br> 2–3 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [6–9 December 2021](2021-12-09-UniqueResearch.html) | Unique Research <br> profil | 24–30% <br> 5–6 | 24–30% <br> 5–6 | 15–20% <br> 3–4 | 9–13% <br> 1–3 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [6–9 December 2021](2021-12-09-Market.html) | Market <br> Der Standard | 21–27% <br> 4–6 | 23–29% <br> 5–6 | 19–25% <br> 4–5 | 10–14% <br> 2–3 | 9–13% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [6–9 December 2021](2021-12-09-IFDD.html) | IFDD <br> PULS 24 | 20–27% <br> 4–5 | 23–30% <br> 4–6 | 17–23% <br> 3–5 | 10–15% <br> 2–3 | 10–15% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [23–25 November 2021](2021-11-25-OGM.html) | OGM <br> KURIER | 20–26% <br> 4–5 | 23–29% <br> 5–6 | 18–24% <br> 4–5 | 10–14% <br> 2–3 | 10–14% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [15–18 November 2021](2021-11-18-UniqueResearch.html) | Unique Research <br> profil | 21–27% <br> 4–6 | 22–28% <br> 4–6 | 17–23% <br> 3–5 | 11–16% <br> 2–3 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [8–11 November 2021](2021-11-11-UniqueResearch.html) | Unique Research <br> Heute | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [18–21 October 2021](2021-10-21-PeterHajek.html) | Peter Hajek <br> APA and ATV | 20–26% <br> 4–5 | 20–26% <br> 4–5 | 17–23% <br> 3–5 | 14–19% <br> 3–4 | 10–14% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [12–15 October 2021](2021-10-15-UniqueResearch.html) | Unique Research <br> profil | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [12–15 October 2021](2021-10-15-OGM.html) | OGM <br> KURIER | 24–29% <br> 5–6 | 22–27% <br> 4–5 | 19–23% <br> 4–5 | 10–14% <br> 2–3 | 10–14% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [11–12 October 2021](2021-10-12-Market.html) | Market <br> Der Standard | 24–30% <br> 5–6 | 22–28% <br> 4–6 | 18–24% <br> 4–5 | 9–13% <br> 1–2 | 11–16% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [7–11 October 2021](2021-10-11-IFDD.html) | IFDD | 24–28% <br> 5–6 | 23–27% <br> 4–5 | 19–23% <br> 4 | 10–13% <br> 2 | 10–13% <br> 2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [7–9 September 2021](2021-09-09-OGM.html) | OGM <br> KURIER | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [6–11 August 2021](2021-08-11-Market.html) | Market <br> Der Standard | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [2–5 August 2021](2021-08-05-UniqueResearch.html) | Unique Research <br> profil | 32–38% <br> 6–8 | 18–24% <br> 3–5 | 16–22% <br> 3–4 | 10–14% <br> 2–3 | 9–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [15–21 July 2021](2021-07-21-IFDD.html) | IFDD <br> PULS 24 | 32–38% <br> 6–8 | 19–25% <br> 4–5 | 16–22% <br> 3–4 | 9–13% <br> 1–2 | 10–14% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [5–8 July 2021](2021-07-08-UniqueResearch.html) | Unique Research <br> profil | 31–37% <br> 6–8 | 19–25% <br> 4–5 | 15–20% <br> 3–4 | 10–14% <br> 2–3 | 10–14% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [28 June–2 July 2021](2021-07-02-IFDD.html) | IFDD <br> PULS 24 | 30–36% <br> 6–7 | 21–27% <br> 4–5 | 15–21% <br> 3–4 | 10–14% <br> 2–3 | 10–14% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [28 June–1 July 2021](2021-07-01-UniqueResearch.html) | Unique Research <br> Heute | 32–38% <br> 6–8 | 19–25% <br> 4–5 | 15–20% <br> 3–4 | 11–16% <br> 2–3 | 10–14% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [29–30 June 2021](2021-06-30-Market.html) | Market <br> Der Standard | 28–34% <br> 6–7 | 23–29% <br> 5–6 | 15–20% <br> 3–4 | 11–16% <br> 2–3 | 9–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [21–24 June 2021](2021-06-24-PeterHajek.html) | Peter Hajek | 31–37% <br> 6–8 | 20–26% <br> 4–5 | 15–21% <br> 3–4 | 9–13% <br> 1–2 | 10–14% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [22–24 June 2021](2021-06-24-OGM.html) | OGM <br> KURIER | 30–36% <br> 6–7 | 22–28% <br> 4–6 | 15–21% <br> 3–4 | 9–13% <br> 1–2 | 9–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [10–15 June 2021](2021-06-15-IFDD.html) | IFDD <br> PULS 24 | 29–35% <br> 6–7 | 24–30% <br> 5–6 | 16–21% <br> 3–4 | 9–13% <br> 1–2 | 9–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [7–10 June 2021](2021-06-10-UniqueResearch.html) | Unique Research <br> profil | 30–36% <br> 6–8 | 20–26% <br> 4–5 | 15–21% <br> 3–4 | 11–16% <br> 2–3 | 9–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [8–10 June 2021](2021-06-10-Market.html) | Market <br> Der Standard | 29–35% <br> 6–7 | 24–30% <br> 5–6 | 14–19% <br> 2–4 | 11–15% <br> 2–3 | 9–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [24–30 May 2021](2021-05-30-Market.html) | Market | 26–32% <br> 5–6 | 25–31% <br> 5–6 | 18–23% <br> 3–4 | 8–12% <br> 1–2 | 9–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [14 May 2021](2021-05-14-DemoxResearch.html) | Demox Research | 30–36% <br> 6–8 | 20–26% <br> 4–5 | 16–21% <br> 3–4 | 10–14% <br> 2–3 | 9–13% <br> 2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [10–12 May 2021](2021-05-12-UniqueResearch.html) | Unique Research <br> profil | 31–37% <br> 6–8 | 20–26% <br> 4–5 | 15–21% <br> 3–4 | 10–14% <br> 2–3 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [26–29 April 2021](2021-04-29-PeterHajek.html) | Peter Hajek <br> APA and ATV | 30–36% <br> 6–8 | 22–28% <br> 4–6 | 15–21% <br> 3–4 | 11–16% <br> 2–3 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [5–8 April 2021](2021-04-08-UniqueResearch.html) | Unique Research <br> profil | 30–36% <br> 6–8 | 21–27% <br> 4–5 | 16–22% <br> 3–4 | 10–14% <br> 2–3 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [30 March–1 April 2021](2021-04-01-OGM.html) | OGM <br> KURIER | 32–38% <br> 6–8 | 21–27% <br> 4–5 | 15–20% <br> 3–4 | 9–13% <br> 1–2 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [26–30 March 2021](2021-03-30-Market.html) | Market <br> Der Standard | 33–39% <br> 7–8 | 23–29% <br> 4–6 | 13–18% <br> 2–3 | 10–14% <br> 2–3 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [23–25 March 2021](2021-03-25-UniqueResearch.html) | Unique Research <br> Heute | 33–39% <br> 6–8 | 20–26% <br> 4–5 | 15–21% <br> 3–4 | 9–13% <br> 1–2 | 9–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [8–11 March 2021](2021-03-11-PeterHajek.html) | Peter Hajek <br> APA and ATV | 32–38% <br> 6–8 | 22–28% <br> 4–6 | 15–20% <br> 3–4 | 8–12% <br> 1–2 | 9–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [1–4 March 2021](2021-03-04-UniqueResearch.html) | Unique Research <br> profil | 32–38% <br> 6–8 | 21–27% <br> 4–5 | 15–20% <br> 3–4 | 8–12% <br> 1–2 | 10–14% <br> 2–3 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [15–17 February 2021](2021-02-17-Market.html) | Market <br> Der Standard | 34–40% <br> 7–8 | 22–28% <br> 4–6 | 12–16% <br> 2–3 | 10–14% <br> 2–3 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [8–11 February 2021](2021-02-11-UniqueResearch.html) | Unique Research <br> profil | 33–39% <br> 7–8 | 20–26% <br> 4–5 | 15–20% <br> 3–4 | 8–12% <br> 1–2 | 9–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [25 January–1 February 2021](2021-02-01-IFDD.html) | IFDD <br> Kronen Zeitung | 32–38% <br> 6–8 | 21–27% <br> 4–5 | 15–21% <br> 3–4 | 8–12% <br> 1–2 | 9–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [11–14 January 2021](2021-01-14-UniqueResearch.html) | Unique Research <br> profil | 34–40% <br> 7–8 | 19–25% <br> 4–5 | 14–19% <br> 2–4 | 12–17% <br> 2–3 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [17–21 December 2020](2020-12-21-Market.html) | Market <br> Der Standard | 36–42% <br> 7–9 | 20–26% <br> 4–5 | 11–15% <br> 2–3 | 12–17% <br> 2–3 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [15–17 December 2020](2020-12-17-OGM.html) | OGM <br> KURIER | 37–44% <br> 7–9 | 20–26% <br> 4–5 | 11–16% <br> 2–3 | 11–16% <br> 2–3 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [8–12 December 2020](2020-12-12-PeterHajek.html) | Peter Hajek <br> APA and ATV | 36–42% <br> 7–9 | 19–25% <br> 4–5 | 14–19% <br> 2–4 | 11–16% <br> 2–3 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [5 December 2020](2020-12-05-UniqueResearch.html) | Unique Research <br> profil | 37–43% <br> 7–9 | 17–23% <br> 3–5 | 13–18% <br> 2–3 | 11–16% <br> 2–3 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [30 November–2 December 2020](2020-12-02-Market.html) | Market <br> Der Standard | 36–42% <br> 7–9 | 20–26% <br> 4–5 | 12–17% <br> 2–3 | 12–17% <br> 2–3 | 6–10% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [2–6 November 2020](2020-11-06-UniqueResearch.html) | Unique Research | 35–41% <br> 7–9 | 18–24% <br> 4–5 | 14–19% <br> 3–4 | 10–14% <br> 2–3 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [20–22 October 2020](2020-10-22-OGM.html) | OGM | 38–42% <br> 8–9 | 21–25% <br> 4–5 | 10–13% <br> 2 | 14–18% <br> 3 | 7–9% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [12–16 October 2020](2020-10-16-UniqueResearch.html) | Unique Research | 37–43% <br> 7–9 | 19–25% <br> 4–5 | 11–16% <br> 2–3 | 11–16% <br> 2–3 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [14–18 September 2020](2020-09-18-UniqueResearch.html) | Unique Research | 36–42% <br> 7–9 | 17–23% <br> 3–4 | 14–19% <br> 2–4 | 14–19% <br> 2–4 | 6–10% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [10–13 August 2020](2020-08-13-UniqueResearch.html) | Unique Research <br> profil | 38–44% <br> 8–9 | 15–21% <br> 3–4 | 13–18% <br> 2–3 | 14–19% <br> 2–4 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [13–16 July 2020](2020-07-16-UniqueResearch.html) | Unique Research <br> profil | 38–44% <br> 8–9 | 16–22% <br> 3–4 | 13–18% <br> 2–3 | 14–19% <br> 2–4 | 6–10% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [23–25 June 2020](2020-06-25-OGM.html) | OGM | 39–45% <br> 8–10 | 16–22% <br> 3–4 | 11–16% <br> 2–3 | 14–19% <br> 2–4 | 6–10% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [9–12 June 2020](2020-06-12-UniqueResearch.html) | Unique Research <br> profil | 41–47% <br> 8–10 | 15–20% <br> 3–4 | 12–17% <br> 2–3 | 14–19% <br> 2–4 | 6–10% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [5–9 June 2020](2020-06-09-KarmasinResearchIdentity.html) | Karmasin Research & Identity | 39–45% <br> 8–10 | 17–22% <br> 3–4 | 11–15% <br> 2–3 | 13–17% <br> 2–3 | 6–10% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [21–26 May 2020](2020-05-26-Market.html) | Market <br> Der Standard | 41–47% <br> 8–10 | 17–23% <br> 3–4 | 10–14% <br> 2–3 | 14–19% <br> 2–4 | 5–9% <br> 1 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [18–19 May 2020](2020-05-19-Market.html) | Market <br> Der Standard | 40–46% <br> 8–9 | 19–24% <br> 4–5 | 10–14% <br> 2–3 | 15–19% <br> 3–4 | 5–8% <br> 1 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [11–14 May 2020](2020-05-14-UniqueResearch.html) | Unique Research <br> profil | 43–49% <br> 9–10 | 15–20% <br> 3–4 | 12–17% <br> 2–3 | 13–18% <br> 2–3 | 5–8% <br> 0–1 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [11–13 May 2020](2020-05-13-Market.html) | Market <br> Der Standard | 41–47% <br> 8–10 | 19–24% <br> 3–5 | 9–13% <br> 1–2 | 15–19% <br> 3–4 | 5–8% <br> 1 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [20–22 April 2020](2020-04-22-Market.html) | Market | 41–47% <br> 8–10 | 18–23% <br> 3–4 | 8–12% <br> 1–2 | 16–21% <br> 3–4 | 6–9% <br> 1 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [13–16 April 2020](2020-04-16-UniqueResearch.html) | Unique Research <br> profil | 45–51% <br> 9–11 | 14–19% <br> 2–4 | 11–16% <br> 2–3 | 14–19% <br> 2–4 | 5–8% <br> 0–1 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [3–7 April 2020](2020-04-07-Market.html) | Market <br> Der Standard | 42–46% <br> 8–10 | 17–21% <br> 3–4 | 10–13% <br> 2 | 17–21% <br> 3–4 | 5–7% <br> 1 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [31 March–2 April 2020](2020-04-02-OGM.html) | OGM | 42–48% <br> 9–10 | 14–19% <br> 2–4 | 10–14% <br> 2–3 | 15–21% <br> 3–4 | 5–9% <br> 1 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [24–31 March 2020](2020-03-31-Market.html) | Market <br> Der Standard | 40–46% <br> 8–10 | 17–22% <br> 3–4 | 9–13% <br> 1–2 | 17–22% <br> 3–4 | 6–9% <br> 1 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [9–13 March 2020](2020-03-13-UniqueResearch.html) | Unique Research | 36–42% <br> 7–9 | 14–19% <br> 3–4 | 15–20% <br> 3–4 | 14–19% <br> 3–4 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [11–12 March 2020](2020-03-12-Market.html) | Market <br> Der Standard | 37–43% <br> 7–9 | 18–23% <br> 3–4 | 11–15% <br> 2–3 | 15–19% <br> 3–4 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [10–14 February 2020](2020-02-14-UniqueResearch.html) | Unique Research <br> profil | 35–41% <br> 7–9 | 13–18% <br> 2–3 | 14–19% <br> 2–4 | 15–20% <br> 3–4 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [4–6 February 2020](2020-02-06-Market.html) | Market | 36–42% <br> 7–9 | 16–22% <br> 3–4 | 13–18% <br> 2–3 | 15–20% <br> 3–4 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [10–15 January 2020](2020-01-15-KarmasinResearchIdentity.html) | Karmasin Research & Identity | 36–42% <br> 7–9 | 15–19% <br> 3–4 | 13–17% <br> 2–3 | 15–19% <br> 3–4 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [6–10 January 2020](2020-01-10-UniqueResearch.html) | Unique Research <br> profil | 35–41% <br> 7–9 | 14–19% <br> 2–4 | 14–19% <br> 2–4 | 15–20% <br> 3–4 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [16–19 December 2019](2019-12-19-Market.html) | Market <br> Der Standard | 36–42% <br> 7–9 | 16–22% <br> 3–4 | 12–17% <br> 2–3 | 14–19% <br> 2–4 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [9–13 December 2019](2019-12-13-UniqueResearch.html) | Unique Research <br> profil | 36–42% <br> 7–9 | 15–21% <br> 3–4 | 13–18% <br> 2–3 | 15–20% <br> 3–4 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [29 November–4 December 2019](2019-12-04-Market.html) | Market <br> Der Standard | 36–42% <br> 7–9 | 16–21% <br> 3–4 | 13–18% <br> 2–3 | 14–19% <br> 2–4 | 8–12% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [11–15 November 2019](2019-11-15-UniqueResearch.html) | Unique Research <br> profil | 35–41% <br> 7–9 | 16–22% <br> 3–4 | 15–20% <br> 3–4 | 14–19% <br> 2–4 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [8–13 November 2019](2019-11-13-KarmasinResearchIdentity.html) | Karmasin Research & Identity | 36–40% <br> 7–8 | 19–21% <br> 3–4 | 14–16% <br> 2–3 | 14–16% <br> 2–3 | 8–10% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [15–17 October 2019](2019-10-17-Market.html) | Market <br> Der Standard | 35–41% <br> 7–9 | 17–23% <br> 3–5 | 14–19% <br> 2–4 | 13–18% <br> 2–3 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [7–11 October 2019](2019-10-11-UniqueResearch.html) | Unique Research <br> profil | 34–40% <br> 7–8 | 17–23% <br> 3–5 | 15–20% <br> 3–4 | 13–18% <br> 2–3 | 7–11% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [16–23 September 2019](2019-09-23-OGM.html) | OGM <br> Servus TV | 31–37% <br> 6–8 | 20–25% <br> 4–5 | 18–23% <br> 3–5 | 10–14% <br> 2–3 | 6–10% <br> 1–2 | 1–3% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [12–20 September 2019](2019-09-20-PeterHajek.html) | Peter Hajek <br> ATV, PULS 4 and Servus TV | 32–36% <br> 7–8 | 21–24% <br> 4–5 | 19–21% <br> 4 | 12–14% <br> 2–3 | 7–9% <br> 1–2 | 2–3% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [16–18 September 2019](2019-09-18-Market.html) | Market <br> Der Standard | 32–38% <br> 7–8 | 20–26% <br> 4–5 | 17–23% <br> 3–5 | 9–13% <br> 2 | 6–10% <br> 1–2 | 1–3% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [1–18 September 2019](2019-09-18-InstitutfürGrundlagenforschung.html) | Institut für Grundlagenforschung | 29–35% <br> 6–7 | 16–22% <br> 3–4 | 23–29% <br> 5–6 | 9–14% <br> 1–3 | 6–10% <br> 1–2 | 2–5% <br> 0–1 | N/A <br> N/A | N/A <br> N/A |
| [11–17 September 2019](2019-09-17-KarmasinResearchIdentity.html) | Karmasin Research & Identity | 32–36% <br> 7–8 | 21–24% <br> 4–5 | 19–21% <br> 4 | 12–14% <br> 2–3 | 8–10% <br> 1–2 | 1% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [2–13 September 2019](2019-09-13-UniqueResearch.html) | Unique Research <br> profil | 31–35% <br> 6–8 | 20–24% <br> 4–5 | 18–22% <br> 4 | 12–14% <br> 2–3 | 7–9% <br> 1–2 | 2–3% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [6–13 September 2019](2019-09-13-OGM.html) | OGM <br> KURIER | 33–37% <br> 7–8 | 20–24% <br> 4–5 | 18–22% <br> 4 | 10–12% <br> 2 | 7–9% <br> 1–2 | 1–3% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [5–10 September 2019](2019-09-10-KarmasinResearchIdentity.html) | Karmasin Research & Identity <br> PULS 24 | 33–37% <br> 7–8 | 21–24% <br> 4–5 | 18–20% <br> 3–4 | 11–13% <br> 2 | 8–10% <br> 1–2 | 2–3% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [5–8 September 2019](2019-09-08-Market.html) | Market <br> Der Standard | 31–37% <br> 6–8 | 19–25% <br> 4–5 | 18–24% <br> 3–5 | 8–12% <br> 1–2 | 8–12% <br> 1–2 | 1–3% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [2–4 September 2019](2019-09-04-Market.html) | Market <br> Der Standard | 31–37% <br> 6–8 | 19–25% <br> 4–5 | 18–24% <br> 4–5 | 9–13% <br> 1–2 | 7–11% <br> 1–2 | 1–3% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [29 August–3 September 2019](2019-09-03-KarmasinResearchIdentity.html) | Karmasin Research & Identity <br> PULS 24 | 33–37% <br> 7–8 | 20–22% <br> 4–5 | 19–21% <br> 4 | 11–13% <br> 2 | 8–10% <br> 1–2 | 1% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [19–22 August 2019](2019-08-22-UniqueResearch.html) | Unique Research <br> profil | 33–39% <br> 7–8 | 17–23% <br> 3–5 | 17–23% <br> 3–5 | 10–14% <br> 2–3 | 7–11% <br> 1–2 | 1–2% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [8–12 August 2019](2019-08-12-OGM.html) | OGM <br> KURIER | 32–38% <br> 6–8 | 20–26% <br> 4–5 | 17–23% <br> 3–5 | 9–13% <br> 1–2 | 6–10% <br> 1–2 | 1–3% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [26 July–9 August 2019](2019-08-09-KowarczMarktforschung.html) | Kowarcz Marktforschung | 29–33% <br> 6–7 | 18–22% <br> 4–5 | 20–24% <br> 4–5 | 11–15% <br> 2–3 | 8–11% <br> 1–2 | 1–3% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [2–5 August 2019](2019-08-05-Market.html) | Market <br> Der Standard | 32–38% <br> 6–8 | 19–25% <br> 4–5 | 17–23% <br> 3–5 | 8–12% <br> 1–2 | 8–12% <br> 1–2 | 1–2% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [8–12 July 2019](2019-07-12-UniqueResearch.html) | Unique Research <br> profil | 34–40% <br> 7–8 | 17–23% <br> 3–5 | 18–24% <br> 3–5 | 9–13% <br> 1–2 | 7–11% <br> 1–2 | 1–2% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [8–9 July 2019](2019-07-09-Market.html) | Market <br> Der Standard | 33–39% <br> 7–8 | 18–24% <br> 3–5 | 17–23% <br> 3–4 | 9–13% <br> 1–2 | 8–12% <br> 1–2 | 1–2% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [24–28 June 2019](2019-06-28-PeterHajek.html) | Peter Hajek <br> ATV | 35–41% <br> 7–9 | 17–23% <br> 3–5 | 17–23% <br> 3–5 | 9–13% <br> 1–2 | 7–11% <br> 1–2 | 1–2% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [31 May–10 June 2019](2019-06-10-SORA.html) | SORA <br> ORF | 35–41% <br> 7–9 | 19–24% <br> 4–5 | 16–20% <br> 3–4 | 10–14% <br> 2–3 | 7–10% <br> 1–2 | 1–2% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [5–6 June 2019](2019-06-06-Market.html) | Market <br> Der Standard | 35–41% <br> 7–9 | 19–25% <br> 4–5 | 16–22% <br> 3–4 | 8–12% <br> 1–2 | 7–11% <br> 1–2 | 1–2% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [31 May–5 June 2019](2019-06-05-UniqueResearch.html) | Unique Research | 34–40% <br> 7–8 | 17–23% <br> 3–4 | 18–24% <br> 3–5 | 8–12% <br> 1–2 | 8–12% <br> 1–2 | 1–2% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [29–31 May 2019](2019-05-31-UniqueResearch.html) | Unique Research | 35–41% <br> 7–9 | 18–24% <br> 3–5 | 17–22% <br> 3–4 | 8–12% <br> 1–2 | 8–12% <br> 1–2 | 1–2% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| [1–31 May 2019](2019-05-31-DemoxResearch.html) | Demox Research | 35–41% <br> 7–9 | 20–25% <br> 4–5 | 16–21% <br> 3–4 | 7–10% <br> 1–2 | 9–13% <br> 1–2 | N/A <br> N/A | N/A <br> N/A | N/A <br> N/A |
| [27–29 May 2019](2019-05-29-OGM.html) | OGM <br> KURIER | 33–39% <br> 7–8 | 19–25% <br> 4–5 | 18–24% <br> 4–5 | 8–12% <br> 1–2 | 6–10% <br> 1–2 | 1–3% <br> 0 | N/A <br> N/A | N/A <br> N/A |
| 26 May 2019 | General Election | 34.6% <br> 7 | 23.9% <br> 5 | 17.2% <br> 3 | 14.1% <br> 2 | 8.4% <br> 1 | 1.0% <br> 0 | 0.0% <br> 0 | 0.0% <br> 0 |

Only polls for which at least the sample size has been published are included in the table above.

**Legend:**
+ **Top half of each row:** Voting intentions (95% confidence interval)
+ **Bottom half of each row:** Seat projections for the European Parliament (95% confidence interval)
+ **ÖVP:** Österreichische Volkspartei (EPP)
+ **SPÖ:** Sozialdemokratische Partei Österreichs (S&D)
+ **FPÖ:** Freiheitliche Partei Österreichs (ID)
+ **Grüne:** Die Grünen–Die Grüne Alternative (Greens/EFA)
+ **NEOS:** NEOS–Das Neue Österreich und Liberales Forum (RE)
+ **JETZT:** JETZT–Liste Pilz (Greens/EFA)
+ **GILT:** Meine Stimme Gilt! (*)
+ **HC:** Team HC Strache–Allianz für Österreich (*)
+ **N/A (single party):** Party not included the published results
+ **N/A (entire row):** Calculation for this opinion poll not started yet

